MedPath

Investigation of association between vonoprazan concentration and CYP3A activity in upper gastrointestinal disease

Not Applicable
Recruiting
Conditions
upper gastrointestinal tract disease gastroesophageal reflux disease
Registration Number
JPRN-UMIN000042996
Lead Sponsor
Department of Hospital pharmacy Hamamatsu University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1. Patients discontinuing vonoprazan treatment 2. Patients who are judged by physicians as in appropriate for study enrollment

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath